Literature DB >> 22495110

The treatment of pulmonary sarcoidosis.

Marc A Judson1.   

Abstract

This manuscript offers an approach to the treatment of pulmonary sarcoidosis based on current available information. The treatment of pulmonary sarcoidosis is not mandatory as the disease may be self-limiting and therapy is often associated with significant drug side effects. The decision to treat rests predominantly on the presence of significant symptoms or functional limitation. Corticosteroids are the drug of choice. Alternative agents to corticosteroids may be useful primarily as corticosteroid sparing agents.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22495110     DOI: 10.1016/j.rmed.2012.01.013

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  17 in total

Review 1.  Nonsteroidal therapy of sarcoidosis.

Authors:  Peter Korsten; Mehdi Mirsaeidi; Nadera J Sweiss
Journal:  Curr Opin Pulm Med       Date:  2013-09       Impact factor: 3.155

2.  Physical Activity and Fatigue in Patients with Sarcoidosis.

Authors:  Thomas Bahmer; Henrik Watz; Maria Develaska; Benjamin Waschki; Klaus F Rabe; Helgo Magnussen; Detlef Kirsten; Anne-Marie Kirsten
Journal:  Respiration       Date:  2017-11-09       Impact factor: 3.580

3.  Resolution of chronic ocular sarcoidosis with antimycobacterial therapy.

Authors:  Bradley W Richmond; Kyra Richter; Lloyd E King; Wonder P Drake
Journal:  Case Rep Intern Med       Date:  2014

4.  [Placoid chorioretinal foci of inflammation in combination with prominent hili].

Authors:  Annabelle Eckert; Tilmann Kallinich; Uwe Pleyer
Journal:  Ophthalmologe       Date:  2018-11       Impact factor: 1.059

Review 5.  The Diagnosis, Differential Diagnosis, and Treatment of Sarcoidosis.

Authors:  Antje Prasse
Journal:  Dtsch Arztebl Int       Date:  2016-08-22       Impact factor: 5.594

6.  Imaging Findings of Fibrosis in Pulmonary Sarcoidosis.

Authors:  Michiru Sawahata; Tetsuo Yamaguchi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-06-29       Impact factor: 1.803

7.  Development and testing of item response theory-based item banks and short forms for eye, skin and lung problems in sarcoidosis.

Authors:  David E Victorson; Seung Choi; Marc A Judson; David Cella
Journal:  Qual Life Res       Date:  2013-11-09       Impact factor: 4.147

8.  A conceptual model of health-related quality of life in sarcoidosis.

Authors:  David E Victorson; David Cella; Heidi Grund; Marc A Judson
Journal:  Qual Life Res       Date:  2013-05-26       Impact factor: 4.147

9.  Sex-Steroid Signaling in Lung Diseases and Inflammation.

Authors:  Nilesh Sudhakar Ambhore; Rama Satyanarayana Raju Kalidhindi; Venkatachalem Sathish
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 10.  Current and emerging pharmacological treatments for sarcoidosis: a review.

Authors:  Scott H Beegle; Kerry Barba; Romel Gobunsuy; Marc A Judson
Journal:  Drug Des Devel Ther       Date:  2013-04-12       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.